loadpatents
name:-0.18540287017822
name:-0.076333045959473
name:-0.00050020217895508
Patane; Michael A. Patent Filings

Patane; Michael A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Patane; Michael A..The latest application filed is for "spirocyclic hat inhibitors and methods for their use".

Company Profile
0.26.28
  • Patane; Michael A. - Andover MA US
  • Patane; Michael A. - Waltham MA
  • Patane; Michael A. - Cambridge MA
  • Patane; Michael A. - Reading MA
  • Patane; Michael A. - Billerica MA
  • Patane; Michael A. - Harleysville PA
  • Patane, Michael A - Andover MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ocular iontophoretic delivery of dexamethasone and formulations thereof
Grant 10,376,463 - Jaffe , et al. A
2019-08-13
Spirocyclic Hat Inhibitors And Methods For Their Use
App 20180193315 - Kesicki; Edward A. ;   et al.
2018-07-12
Spirocyclic Hat Inhibitors And Methods For Their Use
App 20180071262 - Kesicki; Edward A. ;   et al.
2018-03-15
Delivery of corticosteroids through iontophoresis
Grant 9,820,935 - Jaffe , et al. November 21, 2
2017-11-21
Prmt5 Inhibitors And Uses Thereof
App 20170198006 - Duncan; Kenneth W. ;   et al.
2017-07-13
Delivery Of Corticosteroids Through Iontophoresis
App 20160263024 - Jaffe; Mike ;   et al.
2016-09-15
7-deazapurine Modulators Of Histone Methyltransferase, And Methods Of Use Thereof
App 20160251390 - Chesworth; Richard ;   et al.
2016-09-01
Spirocyclic Hat Inhibitors And Methods For Their Use
App 20160235716 - Kesicki; Edward A. ;   et al.
2016-08-18
Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20160068559 - Chesworth; Richard ;   et al.
2016-03-10
Delivery of corticosteroids through iontophoresis
Grant 9,149,525 - Jaffe , et al. October 6, 2
2015-10-06
7-deazapurine modulators of histone methyltransferase, and methods of use thereof
Grant 9,145,438 - Chesworth , et al. September 29, 2
2015-09-29
Modulators of histone methyltransferase, and methods of use thereof
Grant 9,029,343 - Chesworth , et al. May 12, 2
2015-05-12
Aminothiazoles And Their Uses
App 20140315790 - Bushell; Simon ;   et al.
2014-10-23
7-deazapurine modulators of histone methyltransferase, and methods of use thereof
Grant 8,722,877 - Chesworth , et al. May 13, 2
2014-05-13
7-Deazapurine Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20140073597 - Chesworth; Richard ;   et al.
2014-03-13
Delivery Of Corticosteroids Through Iontophoresis
App 20140046242 - Jaffe; Mike ;   et al.
2014-02-13
7-Deazapurine Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20130310334 - Chesworth; Richard ;   et al.
2013-11-21
Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20130310333 - Chesworth; Richard ;   et al.
2013-11-21
Delivery Of Corticosteroids Through Iontophoresis
App 20120283231 - Jaffe; Mike ;   et al.
2012-11-08
Aminothiazoles And Their Uses
App 20100267757 - LaMarche; Matthew J. ;   et al.
2010-10-21
Organic Compounds And Their Uses
App 20100204159 - Brandl; Trixl ;   et al.
2010-08-12
Delivery Of Corticosteroids Through Iontophoresis
App 20090306579 - Jaffe; Mike ;   et al.
2009-12-10
Eftu Inhibitors Or Aminothiazoles And Their Uses
App 20080221142 - LaMarche; Matthew J. ;   et al.
2008-09-11
.alpha.v integrin receptor antagonists
Grant 7,153,862 - Askew , et al. December 26, 2
2006-12-26
Dibenzoxazepine .alpha.v integrin receptor antagonist
Grant 6,943,156 - Patane September 13, 2
2005-09-13
Antagonists of melanin concentrating hormone receptor
Grant 6,921,821 - Blackburn , et al. July 26, 2
2005-07-26
Compounds, pharmaceutical compositions and methods of use therefor
App 20050143372 - Ghosh, Shomir ;   et al.
2005-06-30
Integrin receptor antagonists
Grant 6,784,190 - Askew , et al. August 31, 2
2004-08-31
Antagonists of melanin concentrating hormone receptor
App 20040106645 - Blackburn, Christopher ;   et al.
2004-06-03
.alpha.v integrin receptor antagonists
Grant 6,693,101 - Askew , et al. February 17, 2
2004-02-17
Alpha V integrin receptor antagonists
App 20040019037 - Askew, Ben C. ;   et al.
2004-01-29
Dibenzoxazepine alpha v integrin receptor antagonist
App 20040019035 - Patane, Michael A
2004-01-29
.alpha.V integrin receptor antagonists
Grant 6,472,403 - Duggan , et al. October 29, 2
2002-10-29
Alpha V integrin receptor antagonists
App 20020037889 - Duggan, Mark E. ;   et al.
2002-03-28
Integrin receptor antagonists
App 20020010176 - Askew, Ben C. ;   et al.
2002-01-24
Alpha V integrin receptor antagonists
App 20010053853 - Askew, Ben C. ;   et al.
2001-12-20
Integrin receptor antagonists
Grant 6,297,249 - Duggan , et al. October 2, 2
2001-10-02
Alpha 1a adrenergic receptor antagonists
Grant 6,255,315 - Patane , et al. July 3, 2
2001-07-03
Dihydropyrimidines and uses thereof
Grant 6,228,861 - Nagarathnam , et al. May 8, 2
2001-05-08
Dihydropyrimidines and uses thereof
Grant 6,172,066 - Nagarathnam , et al. January 9, 2
2001-01-09
Alpha 1a adrenergic receptor antagonists
Grant 6,143,750 - Patane , et al. November 7, 2
2000-11-07
Integrin receptor antagonists
Grant 6,048,861 - Askew , et al. April 11, 2
2000-04-11
Alpha 1a adrenergic receptor antagonists
Grant 6,037,354 - Patane , et al. March 14, 2
2000-03-14
Integrin receptor antagonists
Grant 6,017,926 - Askew , et al. January 25, 2
2000-01-25
Alpha 1a adrenergic receptor antagonist
Grant 5,807,856 - Bock , et al. September 15, 1
1998-09-15
Process for making dihydropyrimidinones
Grant 5,786,472 - Hu , et al. July 28, 1
1998-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed